Douglas G. Watson

Douglas G.
Watson founded Pittencrieff Glen Associates in 1999, where he is working as Chief Executive Officer from 2011.
Mr. Watson also currently works at ImmunSYS, Inc., as Director, Syncromune, Inc., as Director, and The Chartered Institute of Management Accountants, as Member from 2009.
Mr. Watson also formerly worked at Ciba-Geigy Corp., as President & Chief Executive Officer in 1996, Novartis Corp., as President & Chief Executive Officer from 1997 to 1999, Valigen NV, as President & Chief Executive Officer from 2000 to 2001, Dendreon Corp., as Chairman from 2014 to 2015, OraSure Technologies, Inc., as Chairman from 2002 to 2016, Genta, Inc., as Vice Chairman from 2002 to 2011, Javelin Pharmaceuticals, Inc., as Chairman from 2004 to 2010, Freedom House Foundation, as Chairman, Engelhard Corp., as Director from 1991 to 2006, Summit Bank Corp.
(Georgia), as Director, Delcath Systems, Inc., as Director from 2010 to 2011, Informedix Holdings, Inc., as Director, Intrac, Inc., as Director, Wright Medical Group, Inc., as Independent Director from 2014 to 2015, Innovative Drug Delivery Systems, Inc., as Director, BioMimetic Therapeutics, Inc., as Director in 1999, Accelerated Pharma, Inc., as Independent Director, BASF Catalysts LLC, as Director, Pharmaceutical Research & Manufacturers of America, as Director, American Liver Foundation, as Director, Informedix, Inc., as Director from 2002 to 2006, BZL Biologics, Inc., as Director, BioElectronics, Inc., as Director from 2002 to 2006, Bionor Immuno AS, as Director, and Ciba Pharmaceuticals, as President from 1986 to 1996.
Mr. Watson received his graduate degree from Churchill College.